GlassScriptPhysician profile
Anton N Galich
NPI 1487605226
$4,868.85
in general payments reported to CMS, 2019-2025
46 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $996 · 2020: $547 · 2021: $519 · 2022: $559 · 2023: $696 · 2024: $384 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,249.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $786.95 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Coloplast Corp | $670.34 | 2019-2025 | |
| Astellas Pharma US INC | $406.87 | 2019-2023 | Myrbetriq |
| Medtronic, INC. | $330.42 | 2021-2022 | |
| Histosonics, INC. | $297.44 | 2025 | |
| Abbvie INC. | $217.12 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $213.66 | 2024-2025 | |
| Olympus America INC. | $166.92 | 2019-2025 | Itind System |
| Urovant Sciences INC | $124.88 | 2021-2022 | |
| Amgen INC. | $104.66 | 2019-2022 | |
| Allergan, INC. | $97.66 | 2019 | |
| Myriad Genetic Laboratories, INC. | $88.42 | 2021-2025 | Prolaris |
| Blue Earth Diagnostics | $86.01 | 2019-2022 | |
| Immunitybio, INC. | $78.89 | 2025 | |
| Neotract INC. | $78.26 | 2019-2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Galich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.